🧵 In the US, until recently, your chances of receiving a donated #liver w/in 30 days would vary significantly depending on where you lived—as low as 1%, or as high as 60%. Remember Steve Jobs' speedy liver transplant? He got on multiple waitlists...🧵 columbiasurgery.org/news/end-liver…
For decades, experts and providers have been pressing for a more equitable system of organ allocation, one that would even the odds between, say, a patient in a dense urban center with a long waitlist and a patient in a more rural, statistically healthier area with a short one.
For almost 50 years, the system in place was an outgrowth of informal sharing networks between doctors and medical centers, resulting in a web of organ procurement organizations (OPOs) and donation service areas (DSAs) spread out across the country. #donatelife @UNOSNews
“OPOs are all different shapes and sizes,” says Dr. Jean Emond, Vice Chairman of Surgery and Chief of Transplantation Services at Columbia University. “They’re a little bit like gerrymanders in Congress.” #donatelifemonth
“I was involved in a number of UNOS committees over the years that were trying to tackle liver distribution,” says Dr. Emond. Demand for donated livers became so high in the ’90s that people still refer to the era as “the liver wars.” “scarcity—where rationing had to take place.”
Dr. Emond’s efforts, and those of many other advocates, were recently rewarded with a new liver distribution policy. After spending some time tied up in federal courts, the policy was finally approved and implemented in early 2020.
Patients who need livers will no longer be solely reliant on the OPO in which they happen to live. Rather, patients within a 500-nautical-mile radius of the donation hospital will be considered as recipients, and ultimately selected based on the severity of their medical need.
“What happened for us in New York is that we immediately were exposed to a much larger geographic area of organ donors,” says Dr. Emond. “So we were able to see more transplants and do more transplants.” @americanliverny#Transplant 🧵
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Significant research among children, adolescents, & adults demonstrates that access to gender-affirming therapy and gender-affirming interventions greatly improves mental health, health outcomes, and saves lives. #TransHealthcare
We talked to Dr. Melina Wald about what it means to treat the whole person. Gender-affirming care is an evidence-based approach to health that is focused on instilling pride and celebration of gender diversity. columbiasurgery.org/news/what-gend…#ProtectTransYouth#TransIsBeautiful
Tomorrow! Join our Instagram live chat on gender identity care at 1pm. Feel free to DM us with your questions or bring them to the chat.
Interesting @NYPost story—do street lamps cause thyroid cancer? We asked endocrinologist Dr. Pinar Smith to give perspective. Thread 1/6 nypost.com/2021/02/08/str…
"The article raises the question: does 'light at night' specifically means city lights? Could someone watching TV or using their computer/device at night also influence risk? Maybe the study could have also incorporated 'screen time' after dark as a variable." 2/6
Heart failure deaths are increasing rapidly, and one key factor in the rise? The majority of treatment in the U.S. is stuck in the past, most physicians' mindsets haven't evolved. (thread)
"You know, [the rise in heart failure deaths] is a critical question not enough people are addressing," says @NirUrielMD. "Heart failure historically was a disease that a primary physician or cardiologist could treat, or theoretically, every doctor could. But it's evolved."
"Instead, [the majority of physicians] think they can take care of these patients, and when they identify that they cannot anymore and the patient is too sick, they offer the patient hospice care. Yet that patient missed out on the near entirety of treatment," says @NirUrielMD.
Donna Farber is an immunologist who studies the immune response to respiratory viruses, lung immunity, and human immunology. The COVID-19 and Immunology webinar starts now! Follow along #FarberCOVID19
COVID-19 symptom breakdown (based on 72,314 cases in China)
-1% asymptomatic
-81% acute disease w/out pneumonia
-14% severe disease
-5% critical
Case mortality=2.3% (*23 times more lethal than influenza) #FarberCOVID19
Risk factors for severe disease: middle to old age; male; comorbidities (heart disease, diabetes, hypertension)
Less than 10% of cases are under 30 years old.
Treatment is supportive care, no anti-viral or vaccine therapies #FarberCOVID19